Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib

Research output: Contribution to journalArticle

1 Scopus citations

Fingerprint

Dive into the research topics of 'Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib'. Together they form a unique fingerprint.

Medicine & Life Sciences